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Abstract 
Sarcoidosis is a multisystem disease that most commonly involves the lungs and the 
lymph nodes, but with genitourinary tract involvement, can easily mimic testicular 
cancer with metastasis to the lungs. We describe the case of a 30-year-old African-
American male who presented with complaints of a headache, skin lesions, and a scrotal 
mass. A computed tomography scan of the head showed lesions in the frontotemporal 
and pons region, causing obstructive hydrocephalus. An ultrasound of the scrotum 
showed an enlarged epididymis bilaterally as well as a solid hypoechoic ill-defined mass 
on the right side, separate from the intact testis. Given the high suspicion for testicular 
malignancy with brain metastasis, a right orchiectomy was completed. The pathology 
revealed non-caseating necrotizing granulomas that stained negative for tubercular and 
fungal organisms, which was consistent with sarcoidosis. Additionally, the patient’s skin 
and central nervous system (CNS) lesions improved on steroids that had been started for 
cerebral edema. Given the predilection of testicular cancer for CNS metastasis, 
neurosarcoidosis can also be mistaken for testicular cancer metastasis to the CNS, as 
seen in our case. Differentiating testicular cancer from genitourinary sarcoidosis is 
difficult but can be clarified using a combination of clinical presentation, epidemiology, 
serum markers (ACE, AFP, B-HCG), biopsies from skin/lymph nodes, and sometimes 
imaging. It is critical to differentiate genitourinary sarcoidosis from malignancy, as a 
misdiagnosis can lead to unnecessary surgical interventions, which have important 
implications for future fertility. There can also be a coexistence of as well as an 
association between testicular cancer and sarcoidosis, which should be recognized by 
health care providers. 
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A 30-year-old African-American male presented with a 3-week history of a gradually progressive 
frontal headache, with enlarging skin nodules and a progressively enlarging painless right hemiscrotal 
mass during the past year. The patient’s mother and several first-degree relatives had a history of 
sarcoidosis. The patient denied any history of contact with tuberculosis, fever, anorexia, weight loss, 
hematuria, testicular pain, cough or visual disturbances. A PPD test (tuberculin skin test) taken 2 
months before admission was negative. Vitals on presentation were unremarkable, and pertinent 
positive physical examination findings included an indurated, nodular lesion on the upper lip, with a 
lesion on the left nasolabial fold. There was no palpable lymphadenopathy. Laboratory studies such as 
complete metabolic panel, complete blood count, and urinalysis were within normal limits. A computed 
tomography (CT) scan of the head showed lesions in the frontotemporal and pons region, causing 
obstructive hydrocephalus. A CT of the chest did not reveal any hilar/mediastinal lymphadenopathy or 
evidence of sarcoidosis, and a CT of the abdomen/pelvis demonstrated a hydrocele with a right 
hemiscrotal mass without any lymphadenopathy. An ultrasound of the scrotum showed an enlarged 
epididymis bilaterally as well as a solid hypoechoic ill-defined mass on the right side (fig. 1), separate 
from the intact testis. Laboratory work-up for testicular malignancy revealed normal human chorionic 
gonadotropin (HCG), LDH and alpha fetoprotein (AFP) levels. A HIV antibody and a repeat PPD test 
were nonreactive. Given the high suspicion for testicular malignancy with brain metastasis, a right 
orchiectomy was completed, with the subsequent pathology days later displaying a normal testis with a 
distorted architecture of the epididymis. Pathology also identified granulomas (fig. 2, fig. 3, fig. 4) that 
stained negative for fungal organisms as well as for Mycobacterium tuberculosis. Aspirated hydrocele 
fluid did not reveal any bacterial, fungal or mycobacterial growth. At the time of presentation, the 
patient was initiated on steroids, given the concern for cerebral edema from a central nervous system 
(CNS) malignancy. The patient’s headache improved and his skin lesions started to resolve within a few 
days. Based on the clinical presentation, his family history, response to steroids and the testicular 
pathology report, a diagnosis of sarcoidosis was made. The patient was discharged on prednisone for a 
3-month time period. A follow-up head CT showed a decrease in the patient’s obstructive 
hydrocephalus as well as a decrease in size of the CNS lesions. 
Discussion 
Testicular malignancy, which is the most common tumor in young males, is the 
leading differential that must be ruled out in males younger than 35 years old who 
experience scrotal swelling or a scrotal mass, especially given the fact that genitourinary 
sarcoidosis is also likely to present in this same population. In fact, testicular cancer and 
sarcoidosis can be very difficult to distinguish. For example, there are reported cases 
where systemic sarcoidosis has been interpreted as metastatic testicular cancer, leading to 
inadvertent chemotherapy [1] as well as orchiectomy (as in our case). It is also critical to 
distinguish sarcoidosis from testicular cancer early on, as testicular cancer requires 
aggressive surgery and systemic chemotherapy, especially given the favorable response to 
chemotherapy in testicular cancer. 
Thus, how can testicular cancer be differentiated from sarcoidosis? There are subtleties 
that help distinguish the two from each other epidemiologically, serologically, and 
pathologically. Generally, testicular cancer affects Caucasian males while sarcoidosis is 
more common among African-American males [2]. However, the rates of testicular 
cancers are rising in African-American males [2]. The imaging modalities in evaluating 
testicular masses (ultrasound) can be helpful in differentiating sarcoidosis from testicular 
cancer, but often times it is unrevealing (as seen in our patient). Serum markers can also 
be extremely helpful in the differentiation between these two conditions, as serum 
angiotensin-converting enzyme (ACE) is elevated in 75% of untreated active sarcoidosis 
patients, but not in patients with testicular cancer [2]. Additionally, in non-seminoma  
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testicular cancers, serum AFP and beta-HCG (B-HCG) levels are elevated in 
approximately 50% of patients [2]. Lastly, pathology of an extratesticular lesion may be 
very useful in differentiation. Biopsy of skin lesions in sarcoidosis or endoscopic 
ultrasound biopsy of mediastinal lymph nodes can reveal a more definitive diagnosis. In 
our patient, corticosteroids, originally started to decrease cerebral edema due to supposed 
testicular cancer metastasis, subsequently shrunk the CNS lesions. However, this was 
unfortunately after the orchiectomy. 
There is also an association between testicular cancer and sarcoidosis, which seems to 
be not well known to most health care providers. A review of the literature performed by 
Paparel, a urologist at the Memorial Sloan-Kettering Cancer Center, and his colleagues 
[3] noted that there was a coexistence of sarcoidosis or a sarcoid-like reaction in patients 
with testicular cancer. In half of the cases where testicular cancer and sarcoidosis 
coexisted, testicular cancer was diagnosed prior to sarcoidosis. Thirty-one percent of cases 
of testicular cancer that coexisted with sarcoidosis were diagnosed simultaneously. 
Sarcoidosis was associated with different types of testicular cancer, with seminoma being 
the most common. In 80% of these cases with concomitant sarcoidosis, the sarcoidosis 
regressed simultaneously. The coexistence of sarcoidosis and testicular cancer did not 
change the management of testicular cancer or the overall prognosis [3]. With reference 
to the aforementioned, the dilemma arises in cases where a false diagnosis of testicular 
cancer is made, when, in fact, sarcoidosis is the correct diagnosis, as seen in our patient. 
However, given this strong association between sarcoidosis and testicular cancer, it is 
noted that long-term monitoring and follow-up of our patient may be necessary. 
Genitourinary sarcoidosis, although rare, should also be considered in differentials of 
urologic conditions. Pulmonary hilar lymphadenopathy is present in 90% of patients with 
genitourinary sarcoidosis, which makes distinguishing it from malignancy even more 
difficult [4]. Over 80% of patients with genitourinary sarcoidosis present with 
intrathoracic manifestations [5], but approximately 30% present with extrapulmonary 
involvement of the skin, liver, spleen, eyes, CNS, salivary glands, mucosa, joints, heart, 
bone marrow, muscle and kidneys [6]. The frequent involvement of pulmonary 
sarcoidosis can be mistaken for pulmonary metastasis in the setting of genitourinary 
sarcoidosis or a testicular mass [6]. Additionally, there have been case reports of bilateral 
epididymal sarcoidosis presenting without radiological evidence of intrathoracic lesions 
[7]. Similarly, CNS sarcoidosis can be mistaken as CNS metastasis from testicular cancer 
in the setting of a testicular mass [7], which was seen in our patient. Testicular cancer 
does have a predilection for CNS metastasis and is among the 5 most common cancers to 
metastasize to the brain. Furthermore, cases of caseating granulomas have also been 
reported in genitourinary sarcoidosis, which requires sarcoidosis to also be differentiated 
from fungus or tuberculosis [8], which was performed in our case. The differential for 
genitourinary sarcoidosis is broad: tuberculosis, syphilis, sperm granuloma, filarial 
granuloma, lymphogranuloma venereum, granuloma inguinale, blastomycosis, 
coccidiomycosis, actinomycosis, schistosomiasis, and Wegener’s granulomatosis [7] need 
to be ruled out in the evaluation of genitourinary sarcoidosis. Lastly, other malignancies 
such as lymphoma or other genitourinary malignancies besides testicular cancer must be 
considered in the appropriate clinical context. 
The last consideration that clinicians must recognize is that testicular cancer may also 
have a primary extragonadal presentation, which involves an initial presentation without 
testicular involvement. The aforementioned least commonly involves seminomas [9].  
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Lastly, there is an entity called the ‘burned out phenomenon’, in which there is 
extragonadal involvement without any histologic involvement of the testes, which may 
occur in advanced seminoma. In the rare case of the ‘burned out phenomenon’, the area 
of the primary testicular tumor may be replaced by scar tissue. Often, the diagnosis may 
only be made by histologic examination after removal of the testicle. Adjuvant 
radiotherapy or chemotherapy along with testicular removal will be based on the 
histologic diagnosis of the extranodal presentation [9]. 
Thus, management of testicular cancer and genitourinary sarcoidosis should have an 
emphasis on differentiation based on risk factors, serum prognostic markers, skin/lymph 
node biopsies, response to medical treatment, tolerance for surgery, and fertility status. 
Some experts in the field of genitourinary sarcoidosis advocate reserving orchiectomy and 
steroid therapy for severe refractory or disseminated cases, while other experts prefer an 
exploration with intra-operative ultrasound/biopsies/frozen section analysis to rule out 
malignancy [4]. 
Conclusion 
Sarcoidosis is a multisystem disease that most commonly involves the lungs and the 
lymph nodes but, with genitourinary tract involvement, can easily mimic testicular cancer 
with metastasis to the lungs. Given the predilection of testicular cancer for CNS 
metastasis, neurosarcoidosis can also be mistaken for CNS testicular cancer metastasis, as 
seen in our case. Differentiating testicular cancer from genitourinary sarcoidosis is 
difficult but can be clarified using a combination of clinical presentation, epidemiology, 
serum markers (ACE, AFP, B-HCG), biopsies from skin/lymph nodes, and sometimes 
imaging. It is critical to differentiate genitourinary sarcoidosis from malignancy, as a 
misdiagnosis can lead to unnecessary surgical interventions, which have important 
implications for future fertility. There can also be a coexistence of testicular cancer and 
sarcoidosis, which should be recognized by health care providers. 
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Fig. 2. Photomicrograph showing a granulomatous inflammation next to the testes. 
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Fig. 4. Photomicrograph showing necrosis within noncaseating granulomas. 
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